161

Public Health & Prevention
Focuses on global human health and epidemic prevention.
Sub Categories on Public Health & Prevention
{{items.name}}
For severe babesiosis, red blood cell exchange is associated with markedly improved outcomes
Public Health & Prevention
For severe babesiosis, red blood cell exchange is associated with markedly improved outcomes
June 09,2026
Superbugs on your plate: How antimicrobial resistance spreads through food
Public Health & Prevention
Superbugs on your plate: How antimicrobial resistance spreads through food
June 13,2026
Latest Articles
SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator
Updated on: April 22,2024
SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator
Updated on:April 22,2024
New technology 'lights up' bacteria in wounds for better infection prevention

New technology 'lights up' bacteria in wounds for better infection prevention

byUniversity of Southern CaliforniaCredit: Unsplash/CC0 Public DomainOver 6.5 million Americans experience chronic wounds—wounds that do not heal after a few months. Almost all such wounds conta
Updated on: September 10,2024
New technology 'lights up' bacteria in wounds for better infection prevention

New technology 'lights up' bacteria in wounds for better infection prevention

byUniversity of Southern CaliforniaCredit: Unsplash/CC0 Public DomainOver 6.5 million Americans experience chronic wounds—wounds that do not heal after a few months. Almost all such wounds conta
Updated on:September 10,2024
'Self-sabotage' prevents immune protection against malaria

'Self-sabotage' prevents immune protection against malaria

by Walter and Eliza Hall InstituteAustralian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itse
Updated on: April 01,2024
'Self-sabotage' prevents immune protection against malaria

'Self-sabotage' prevents immune protection against malaria

by Walter and Eliza Hall InstituteAustralian scientists have for the first time revealed how malaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itse
Updated on:April 01,2024
Older US adults should get another COVID-19 shot, health officials recommend

Older US adults should get another COVID-19 shot, health officials recommend

by Mike StobbeComirnaty, a new Pfizer/BioNTech vaccination booster for COVID-19, is displayed at a pharmacy in Orlando, Fla., on Friday, Sept. 15, 2023. Older U.S. adults should roll up their sleeves
Updated on: March 21,2024
Older US adults should get another COVID-19 shot, health officials recommend

Older US adults should get another COVID-19 shot, health officials recommend

by Mike StobbeComirnaty, a new Pfizer/BioNTech vaccination booster for COVID-19, is displayed at a pharmacy in Orlando, Fla., on Friday, Sept. 15, 2023. Older U.S. adults should roll up their sleeves
Updated on:March 21,2024
Gilead licenses HIV-prevention drug to generic drugmakers

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
Updated on: October 21,2024
Gilead licenses HIV-prevention drug to generic drugmakers

Gilead licenses HIV-prevention drug to generic drugmakers

Credit: Pixabay/CC0 Public DomainUS pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income
Updated on:October 21,2024
Discovery identifies those likely to experience life-threatening dengue fever

Discovery identifies those likely to experience life-threatening dengue fever

by Monash UniversityStudy cohort characteristics. Individuals with a confirmed secondaryDENVinfection were recruited for the study at the onset of fever and followed up for progressio
Updated on: March 13,2024
Discovery identifies those likely to experience life-threatening dengue fever

Discovery identifies those likely to experience life-threatening dengue fever

by Monash UniversityStudy cohort characteristics. Individuals with a confirmed secondaryDENVinfection were recruited for the study at the onset of fever and followed up for progressio
Updated on:March 13,2024
New study highlights importance of targeting unchanging parts of COVID-19 virus

New study highlights importance of targeting unchanging parts of COVID-19 virus

byCorewell HealthCorewell Health COVID-19 sequencing data. (A) Sequencing statistics for samples analyzed at Corewell Health using Illumina chemistry. (B) SARS-CoV-2 genotypes per month from Dec
Updated on: October 05,2024
New study highlights importance of targeting unchanging parts of COVID-19 virus

New study highlights importance of targeting unchanging parts of COVID-19 virus

byCorewell HealthCorewell Health COVID-19 sequencing data. (A) Sequencing statistics for samples analyzed at Corewell Health using Illumina chemistry. (B) SARS-CoV-2 genotypes per month from Dec
Updated on:October 05,2024
Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U
Updated on: April 02,2024
Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

Phase 3 clinical trial: Second-generation COVID vaccine generates high levels of neutralizing antibodies

by University of Washington School of MedicineVaccine GPB510 is a tiny ball of protein studded with 60 copies of the SARS-CoV-2 Spike protein receptor-binding domain (red). Credit: Ian Haydon / U
Updated on:April 02,2024
More News
Categories
Allergy&Clinical immunology
Anesthesiology & Pain
Cardiovascular Diseases
Dermatology
Diabetes & Endocrinology
Emergency Medicine & Critical Care
ENT & HN
Family Medicine
Gastroenterology
General Surgery
Geriatrics
Hematology&Oncology
Infectious Diseases
Nephrology & Urology
Neurology
Nutrition
OB & GYN
Ophthalmology
Orthopedics & Sports medicine
Pediatrics
Plastic Surgery
Psychiatry & Mental Health
Public Health & Prevention
Pulmonology
Rheumatology
Stomatology
Sleep
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com